SUPRAPRP
LIVE

Serial Number

87269712

Owner

ADVANCED NEUROREGENERATIVE THERAPIES, LLC

Attorney

Susan N. Acquista, Esq.

First Use Date

Apr 27, 2015

Filing Date

Dec 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SUPRAPRP Trademark

Serial Number: 87269712 • Registration: 5984748

SUPRAPRP is a trademark filed by ADVANCED NEUROREGENERATIVE THERAPIES, LLC on December 15, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ADVANCED NEUROREGENERATIVE THERAPIES, LLC (2 trademarks)

BOYNTON BEACH, FL 33437

Entity Type: 16

Trademark Details

Filing Date

December 15, 2016

Registration Date

February 11, 2020

First Use Anywhere

April 27, 2015

First Use in Commerce

April 27, 2015

Published for Opposition

September 4, 2018

Goods & Services

Kits comprising at least one receptacle for receipt and separation of blood components from each other used to prepare platelet rich plasma, derived from donors pre-treated with g-csf, such that said platelet rich plasma features mesenchymal and other stem and progenitor cells in addition to platelets

Medical preparations, namely, solutions containing platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for use on, in, or under tissue, bone and organs for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone and periodontum growth and bone, organ or tissue regeneration

Educational services, namely, providing clinical training in the field of advanced regenerative technologies, namely, training for physicians to perform clinical services in the field of advanced regenerative technologies; providing training to prepare and provide preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration

Marketing services in the nature of marketing and business support services for physicians who provide clinical medical practice consultation services in the field of advanced regenerative technologies featuring provision of preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration

Medical, veterinary, hygienic and beauty care services for human beings or animals, namely, the preparation, provision or both in or under tissue, bone or organs, of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 23, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 23, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 24, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 11, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 4, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 3, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 13, 2019 CNRT
ASSIGNED TO EXAMINER
May 31, 2019 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Apr 24, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 24, 2019 AITU
USE AMENDMENT FILED
Apr 12, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 12, 2019 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 30, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 4, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 15, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 30, 2018 PREV
ASSIGNED TO LIE
Jul 20, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 6, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 6, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2018 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 19, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 15, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 19, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 19, 2018 GNFN
FINAL REFUSAL E-MAILED
Apr 19, 2018 GNFR
FINAL REFUSAL WRITTEN
Apr 19, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2018 CRFA
ASSIGNED TO LIE
Feb 28, 2018 ALIE
NOTICE OF REVIVAL - E-MAILED
Feb 19, 2018 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 18, 2018 TROA
PETITION TO REVIVE-GRANTED
Feb 18, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 18, 2018 PROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2018 TCCA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 9, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 9, 2018 ABN2
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 12, 2017 GPRN
PRIORITY ACTION E-MAILED
Jul 12, 2017 GPRA
PRIORITY ACTION WRITTEN
Jul 12, 2017 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2016 NWOS
NEW APPLICATION ENTERED
Dec 19, 2016 NWAP